United Therapeutics Corporation · NASDAQ:UTHR

Mahon Paul A sold 8,300 United Therapeutics Corporation shares (Form 4)

Traded Jul 16, 2026 · Filed Jul 16, 2026

On Jul 16, 2026, Mahon Paul A (EVP & GENERAL COUNSEL) sold 8,300 United Therapeutics Corporation shares at an average US$533.69 for US$4.43M under a trading plan, leaving 45,172 shares. Filed Jul 16, 2026 (Form 4).

Sold
8,300 shares
Price
US$533.69 average (US$527.60 to US$536.85)
Value
US$4.43M
Holding after
45,172 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP & GENERAL COUNSEL

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 16, 2026Common StockOption exercise8,300US$146.0353,472Direct
Jul 16, 2026Common StockSale600US$527.6052,872Direct
Jul 16, 2026Common StockSale120US$529.8152,752Direct
Jul 16, 2026Common StockSale861US$531.9751,891Direct
Jul 16, 2026Common StockSale800US$532.9451,091Direct
Jul 16, 2026Common StockSale3,279US$534.2147,812Direct
Jul 16, 2026Common StockSale1,041US$535.8846,771Direct
Jul 16, 2026Common StockSale1,519US$534.9945,252Direct
Jul 16, 2026Common StockSale80US$536.8545,172Direct

Source

View original at SEC

Related